Taking a look at Big Pharma’s plan to jab everyone with a warp-speed
COVID-19 vaccine, Children’s Health Defense (CHD) does a quick run-through of
the history of other warp-speed vaccines.
For example, with the backing of, and promotion by, the
World Health Organization, GlaxoSmithKline (GSK) rushed out an adjuvanted H1N1
vaccine in 2009 — only to quickly be met with reports of serious adverse events
connected with the vaccine.
One serious side effect was narcolepsy, which left at least
1,300 children in Europe suffering from it for the rest of their lives. “Documents
obtained by plaintiffs in a series of European lawsuits revealed that GSK knew
about the mounting adverse events associated with Pandemrix in the winter of
2009–including a 5.4-fold increase in death. By December 2009, an injured
person filed a report with GSK for every 12,500 doses of Pandemrix
administered, CHD says.
At the time, the rushed-up vaccine plan did not disclose the
multimillions of dollars that GSK donates to WHO.
Fast-forward to the present pandemic, and you have GSK
scoring $2.1 billion to partner with Sanofi on a COVID-19 vaccine — which, like
the H1N1, is being rushed to market and containing the same AS03 adjuvant that
was included in the 2009 vaccine.
SOURCE: Children’s
Health Defense August 27, 2020